Oncological and reproductive outcomes of organ-sparing treatment of patients of reproductive age with gynaecological malignancies
In the past decade, the clinical practice of treatment of malignant gynaecological tumours has undergone cardinal changes towards introduction of organ-sparing technologies. In many respects, this is due to the fact that women want their reproductive function to be preserved. This approach is widely discussed among medical doctors and: can organ-sparing techniques influence the outcomes of treatment with respect to tumour recurrence and a woman’s reproductive potential and her ability to bear a baby. As has been found, the survival after successful comprehensive treatment of cervical, endometrial and ovarian cancer is high, and the conception and birth of a healthy child is possible in more than 50% of cases, most often with the help of assisted reproductive technologies. Key words: oncological outcomes, tumours, organ-sparing treatment, reproductive outcomes